City

Clinical trials near Guadalajara, Mexico

Active studies with a listed research site in Guadalajara, Mexico.

14active studies

4recruiting now

22countries represented

117largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 3

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Diabetes Mellitus, OverweightCondition

NNC0487-0111, Placebo (matched to NNC0487-0111)Treatment

Argentina, Brazil74 locations

Novo Nordisk A/SSponsor

Updated 2026-09-04 · NCT07533175See eligibility →

Recruiting nowPhase 3

A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)

Obesity, Weight GainCondition

Tirzepatide, PlaceboTreatment

Argentina, Australia69 locations

Eli Lilly and CompanySponsor

Updated 2026-09-04 · NCT06439277See eligibility →

Recruiting nowPhase 3

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Obesity, OverweightCondition

Orforglipron, PlaceboTreatment

Belgium, Brazil117 locations

Eli Lilly and CompanySponsor

Updated 2026-08-24 · NCT06672549See eligibility →

Recruiting nowNot applicable

Postextubation Use of Noninvasive Respiratory Support in Severely Obese Patients

Obesity, Morbid, Extubation FailureCondition

Noninvasive ventilation alternating with high flow nasal cannula, High flow nasal cannulaTreatment

Mexico, United States5 locations

Rush University Medical CenterSponsor

Updated 2026-08-07 · NCT05918575See eligibility →

Opening soonPhase 3

A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes

Diabetes Mellitus, Type 2Condition

Orforglipron, DulaglutideTreatment

Belgium, Brazil71 locations

Eli Lilly and CompanySponsor

Updated 2026-08-19 · NCT07668336See eligibility →

Opening soonPhase 3

BALANCE-DM2 Study of Bofanglutide in Adults With Type 2 Diabetes

Type 2 Diabetes Mellitus (T2DM)Condition

Bofanglutide, SemaglutideTreatment

Mexico7 locations

Carnot LaboratoriesSponsor

Updated 2026-06-05 · NCT07628985See eligibility →

Opening soonPhase 3

BALANCE-OBS: Bofanglutide (GZR18) Versus Semaglutide in Latin American Adults With Overweight or Obesity

Obesity & OverweightCondition

Bofanglutida, SemaglutideTreatment

Mexico6 locations

Carnot LaboratoriesSponsor

Updated 2026-06-03 · NCT07622810See eligibility →

Opening soonNot applicable

INNUPREC (Nutrigenetic Intervention for the Prevention of Cardiovascular Disease)

Abdominal ObesityCondition

Nutrigenetic diet according the genetic test, Control intervention groupTreatment

Mexico1 locations

University of GuadalajaraSponsor

Updated 2025-03-03 · NCT06847243See eligibility →

Invitation onlyNot applicable

Effect of High-intensity Interval Training on Cardiometabolic Health and Physical Fitness in Young Adults With Obesity

Obesity & OverweightCondition

High-intensity interval training intervention, Moderate-intensity continuous training interventionTreatment

Mexico1 locations

Centro Universitario de Tlajomulco, Universidad de GuadalajaraSponsor

Updated 2025-12-15 · NCT07283406See eligibility →

Active, not recruitingPhase 3

Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)

Type 2 DiabetesCondition

Retatrutide, PlaceboTreatment

Argentina, Brazil76 locations

Eli Lilly and CompanySponsor

Updated 2026-07-20 · NCT06297603See eligibility →

Active, not recruitingPhase 3

Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)

Diabetes Mellitus, Type 2Condition

Retatrutide, SemaglutideTreatment

Argentina, Canada77 locations

Eli Lilly and CompanySponsor

Updated 2026-04-13 · NCT06260722See eligibility →

Active, not recruitingPhase 2

A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity

Type 2 Diabetes, ObesityCondition

Tirzepatide, PlaceboTreatment

Argentina, Mexico40 locations

Eli Lilly and CompanySponsor

Updated 2026-03-23 · NCT06037252See eligibility →

Active, not recruitingPhase 4

A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes

Type 2 DiabetesCondition

Tirzepatide, Antihyperglycemic medicationTreatment

Argentina, Canada90 locations

Eli Lilly and CompanySponsor

Updated 2025-12-12 · NCT05433584See eligibility →

Active, not recruitingNot applicable

Effect of a Food Supplement with Natural Extracts of Cocoa, Amaranth Seed and Ginger in Overweight or Obese Patients

Oxidative Stress, Inflammation BiomarkersCondition

Cocoa, amaranth seed and ginger, Amaranth seedTreatment

Mexico1 locations

University of GuadalajaraSponsor

Updated 2025-01-10 · NCT06769035See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.

Clinical trials near Guadalajara, Mexico

Current studies

Related cities